Cardiomyopathy clinical trials
31 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
- The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- Clinical Course Of Disease In Participants With FA-CM
- Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
- Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
- Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
- DeBakey Cardiovascular Magnetic Resonance Study
- Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
- Genetics of Cardiovascular and Neuromuscular Disease
- Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging
- Cardiology Biobank Registry
- Cardiovascular Multimodality Imaging Study
- The Heart Outcomes in Pregnancy Expectations for Mom and Baby Study
- Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
- Technical Development of Cardiovascular Magnetic Resonance Imaging
- Genetic Markers of Cardiovascular Disease in Epilepsy
- Pediatric Cardiomyopathy Mutation Analysis
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
- Large Language Models To Improve the Quality of Care of Cardiology Patients
- Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- PET/CT Imaging in Carriers of TTR Mutations
- PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
- Gut Microbiome Profiling in Patients With Chronic Heart Failure
- Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
- Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Cardiomyopathy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.